论文部分内容阅读
美《国际先驱论坛报》1981年4月3日报道纽约消息:经广泛的研究发现,心脏病猝发的病人服用Timolol可降低发作后引起死亡的危险。根据4月1日发表的一篇报告称,应用这种药物后,病人总的死亡危险性可减少40％,高度危险性病人的死亡率下降到1/2。《新英格兰医学杂志》报道,服药组与不服药组比较,前者很少有明显的第二次发作。挪威一研究组对该药已进行研究,他们的研究是来自20个医院的用药结果,这些医院大约为该国的1/3的人口担任医疗。该研究包括1,884名病人并经过33个月治疗。结果提示,与其它已广泛研究过的药物比较,Timolol对
The International Herald Tribune April 3, 1981 NEW YORK: After extensive research, Timolol has been shown to reduce the risk of death after an attack in a heart attack patient. According to a report published on April 1, the overall risk of death was reduced by 40% after the drug was applied and the mortality rate was reduced to 1/2 in those with high risk. The New England Journal of Medicine reports that there is seldom any significant second episode in the former group compared with the non-medication group. A group of Norwegian researchers have studied the drug, and their research is based on the results of dosing in 20 hospitals, which cover about one-third of the country’s population. The study included 1,884 patients and was treated for 33 months. The results suggest that, compared with other widely studied drugs, Timolol pair